EpiVacCorona is a coronavirus vaccine developed by the Vektor State Research Center of Virology and Biotechnology in Russia. . The antigens-based vaccine provokes an immune reaction against COVID-19 and promotes the further development of immunity.
EpiVacCorona is a coronavirus vaccine developed by the Vektor State Research Center of Virology and Biotechnology in Russia. . The antigens-based vaccine provokes an immune reaction against COVID-19 and promotes the further development of immunity.
The number of people experiencing “long COVID” is unknown, but experts estimate that millions of Americans could be affected. Could an out-of-order immune system be to blame for lingering symptoms? PRODUCTION CREDITS: Produced by: Emily Zendt Production Assistance: Christina Monnen…
The 2019–20 coronavirus pandemic is an ongoing global outbreak of coronavirus disease 2019 (COVID-19), a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Watch this highly educative episode of Health Matta to find out all you…